J. Casey McGlynn, partner at Wilson Sonsini Goodrich & Rosati, joined WSGR in 1978 and formed the Life Sciences Group at the firm in 1990. It is a nationally recognized leader in the representation of startup and emerging growth companies in the life sciences field. Mr. McGlynn has one of the largest practices in the country focused on Medical Devices. Mr. McGlynn has formed, sold and taken public many of the most important medical device companies started during the last 25 years.
Mr. McGlynn has extensive hands on experience in helping entrepreneurs form, build, fund and sell their companies. He has helped to form and participated with the boards of companies in all of the major Medical Device fields, including biologics, cancer, cardiovascular, cardiac surgery, congestive heart failure, cosmetic medicine, diagnostics, electrophysiology, ENT, gastroenterology, general surgery, hearing, imaging, monitoring, neurosurgery, obesity, ophthalmology, orthopedics, peripheral vascular disease, renal therapy, sports medicine, urology, and women’s health.
Over the last 30 years he has built close working relationships with an unparalleled list of entrepreneurs, doctors, investors, engineers, and managers in this industry. Through his portfolio of companies he has met with and negotiated with the leaders of all of the major Medtech acquirers.
Mr. McGlynn was a founding member of BIO and served on the Emerging Company Board of BIO for over a decade. Mr. McGlynn currently serves on the Medical Device Manufacturers Association, a Washington trade organization focused on issues of importance to the biomedical industry. Mr. McGlynn is also a founder and director of Life Science Angels. Since 2005 LSA has invested over $30 million in 40 life science companies that have received an additional $600 million of follow-on funding from venture investors.